Cargando…
CXCL13/CXCR5 signalling is pivotal to preserve motor neurons in amyotrophic lateral sclerosis
BACKGROUND: CXCL13 is a B and T lymphocyte chemokine that mediates neuroinflammation through its receptor CXCR5. This chemokine is highly expressed by motoneurons (MNs) in Amyotrophic Lateral Sclerosis (ALS) SOD1G93A (mSOD1) mice during the disease, particularly in fast-progressing mice. Accordingly...
Autores principales: | Trolese, Maria Chiara, Mariani, Alessandro, Terao, Mineko, de Paola, Massimiliano, Fabbrizio, Paola, Sironi, Francesca, Kurosaki, Mami, Bonanno, Silvia, Marcuzzo, Silvia, Bernasconi, Pia, Trojsi, Francesca, Aronica, Eleonora, Bendotti, Caterina, Nardo, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670099/ https://www.ncbi.nlm.nih.gov/pubmed/33161233 http://dx.doi.org/10.1016/j.ebiom.2020.103097 |
Ejemplares similares
-
Boosting the peripheral immune response in the skeletal muscles improved motor function in ALS transgenic mice
por: Trolese, Maria Chiara, et al.
Publicado: (2022) -
Major Histocompatibility Complex I Expression by Motor Neurons and Its Implication in Amyotrophic Lateral Sclerosis
por: Nardo, Giovanni, et al.
Publicado: (2016) -
Creatine Kinase and Progression Rate in Amyotrophic Lateral Sclerosis
por: Ceccanti, Marco, et al.
Publicado: (2020) -
Up-regulation of neural and cell cycle-related microRNAs in brain of amyotrophic lateral sclerosis mice at late disease stage
por: Marcuzzo, Stefania, et al.
Publicado: (2015) -
Novel P2X7 Antagonist Ameliorates the Early Phase of ALS Disease and Decreases Inflammation and Autophagy in SOD1-G93A Mouse Model
por: Apolloni, Savina, et al.
Publicado: (2021)